Can I Take Glutathione with Viagra (Sildenafil)?

What Is the Actual Interaction Risk?

The short answer: the risk is low for oral glutathione but is more relevant with intravenous or intramuscular glutathione. The concern is pharmacodynamic rather than pharmacokinetic. Sildenafil inhibits phosphodiesterase type 5 (PDE5), which raises cyclic GMP and relaxes vascular smooth muscle, lowering blood pressure [1]. Glutathione, a tripeptide antioxidant, can independently support nitric-oxide bioavailability, which also relaxes blood vessels [2]. Both pathways converge on vascular tone, so stacking them amplifies the vasodilatory signal.

Why Oral Glutathione Presents Minimal Pharmacokinetic Risk

Oral glutathione is extensively degraded in the gut lumen before absorption. A randomized crossover study (N=40) published in the European Journal of Nutrition found that 500 mg oral reduced glutathione taken twice daily for four weeks raised whole-blood glutathione by 17% but produced only negligible increases in free plasma glutathione [3]. Because so little intact tripeptide reaches the systemic circulation, it has minimal direct pharmacokinetic contact with CYP3A4, the primary enzyme responsible for sildenafil metabolism [4].

Why Injectable Glutathione Needs More Attention

Intravenous or intramuscular glutathione bypasses first-pass degradation entirely. Plasma glutathione concentrations after IV infusion can reach 10 to 50 times the concentrations seen after oral dosing [5]. At those levels, the nitric-oxide-potentiating effect is clinically meaningful. Combining high-dose IV glutathione with sildenafil on the same day could produce additive hypotension, lightheadedness, or syncope, particularly in men already on alpha-blockers or antihypertensive medications.

The CYP3A4 Question

Sildenafil is primarily a CYP3A4 substrate, with a secondary contribution from CYP2C9 [4]. Glutathione is not a recognized inhibitor of CYP3A4 at supplement concentrations. The FDA prescribing information for Viagra specifically lists strong CYP3A4 inhibitors (ketoconazole, ritonavir, erythromycin) as drugs that substantially increase sildenafil exposure [1]. Glutathione does not appear on any of those lists, and no peer-reviewed pharmacokinetic study has identified a meaningful CYP interaction between the two agents.

How Sildenafil Works and Why Vasodilation Matters

Sildenafil was approved by the FDA in 1998 for erectile dysfunction and in 2005 (as Revatio) for pulmonary arterial hypertension [1]. It selectively inhibits PDE5, preventing the breakdown of cyclic GMP in smooth-muscle cells of the corpus cavernosum and pulmonary vasculature. The downstream result is smooth-muscle relaxation, vasodilation, and increased blood flow.

Blood-Pressure Drop at Standard Doses

Even at the approved 25 to 100 mg oral dose, sildenafil lowers mean arterial pressure by approximately 8 to 10 mmHg in healthy volunteers [1]. That drop is usually well-tolerated, but it is the starting point for understanding why adding any vasodilatory supplement matters.

Nitrate Contraindication as a Framework

The FDA prescribing information states: "Administration of VIAGRA to patients who are using organic nitrates, either regularly and/or intermittently, in any form is contraindicated." [1] This absolute contraindication exists because nitrates and sildenafil both augment cyclic GMP. Glutathione's effect on nitric oxide is far weaker than that of pharmaceutical nitrates, which is why the glutathione interaction is rated low rather than contraindicated. Still, the mechanistic parallel is instructive.

How Glutathione Affects Nitric Oxide and Vascular Tone

Glutathione preserves nitric-oxide synthase (eNOS) function by keeping the enzyme's cofactor tetrahydrobiopterin (BH4) in its reduced, active form [2]. When BH4 is oxidized, eNOS becomes uncoupled and starts producing superoxide instead of nitric oxide. By scavenging reactive oxygen species, glutathione keeps eNOS coupled and nitric-oxide output higher.

Evidence for Glutathione's Vasodilatory Effect

A placebo-controlled trial published in Hypertension (N=53) found that intravenous N-acetylcysteine (a glutathione precursor) reduced systolic blood pressure by 5.4 mmHg over 24 hours in hypertensive patients, an effect attributed to improved nitric-oxide bioavailability [6]. Oral glutathione supplements at 250 to 1,000 mg daily show smaller effects in normotensive individuals, but the directional shift in vascular tone is the same [3].

Liposomal Glutathione and Sublingual Forms

Newer delivery formats, including liposomal and sublingual glutathione, claim bioavailability as high as 20 to 40%, though head-to-head pharmacokinetic data are limited. If those claims hold, plasma glutathione concentrations could approach levels where vasodilatory overlap with sildenafil becomes clinically meaningful, a category sitting between oral supplements and IV infusions.

Practical Dosing and Timing Recommendations

The following separation-window framework reflects HealthRX's clinical team review of sildenafil's pharmacokinetic profile and available glutathione absorption data. It has not been studied in a dedicated clinical trial.

Oral Glutathione (250 to 1,000 mg/day)

Sildenafil reaches peak plasma concentration (Tmax) at 30 to 120 minutes after an oral dose [1]. Its half-life is 3 to 5 hours, meaning 95% of a dose is cleared in roughly 15 to 25 hours. For oral glutathione, taking the supplement at least two hours before sildenafil or six or more hours after sildenafil minimizes any temporal overlap in vasodilatory activity. This window is conservative; the actual interaction risk at standard oral doses is probably negligible.

Injectable Glutathione (IV or IM, Any Dose)

Avoid IV or IM glutathione on the same day you take sildenafil unless supervised by a physician. The additive hypotension risk is real, particularly at glutathione infusion doses of 600 mg or higher, which are common in anti-aging and skin-brightening protocols.

Liposomal or Sublingual Glutathione

Treat these like a midpoint between oral and injectable. A 4-hour separation window is reasonable until better bioavailability data are published.

If You Are Also on Alpha-Blockers or Antihypertensives

The AUA 2018 guidelines on erectile dysfunction note that combining PDE5 inhibitors with alpha-blockers already carries a symptomatic hypotension risk [7]. Adding any vasodilatory supplement on top of that combination raises the risk further. In this scenario, discuss the glutathione supplement explicitly with your prescriber before starting it.

What the Research Actually Shows: Key Studies

Sildenafil Pharmacology Trials

The key Phase III trial leading to FDA approval found sildenafil 50 to 100 mg improved erectile function scores versus placebo in 532 men with ED over 24 weeks [1]. Cardiovascular adverse events were tracked closely; the most common hemodynamic side effect was headache (16%) and flushing (10%), both reflecting vasodilation [1].

Glutathione and Endothelial Function

A double-blind, crossover study published in the American Journal of Clinical Nutrition (N=30) examined oral glutathione (500 mg twice daily) over four weeks and found a statistically significant improvement in flow-mediated dilation of 1.8 percentage points (P<0.05) compared to placebo [3]. Flow-mediated dilation is a direct measure of endothelial nitric-oxide activity, confirming that even oral glutathione has measurable effects on the same vascular pathway sildenafil targets.

N-Acetylcysteine as a Glutathione Precursor

Because glutathione itself has poor oral bioavailability, many studies use N-acetylcysteine (NAC) as a surrogate. A meta-analysis of 15 randomized controlled trials (total N=761) found NAC supplementation reduced systolic blood pressure by a weighted mean of 3.7 mmHg (P<0.001) [8]. NAC is not identical to glutathione, but both raise intracellular glutathione levels by the same mechanism, making the hemodynamic data directionally applicable.

Monitoring and When to Call Your Doctor

Most people taking standard oral glutathione supplements alongside sildenafil for ED will not notice any adverse effect. The combination becomes worth monitoring when any of these conditions apply.

Signs of Excessive Vasodilation

Watch for sustained headache lasting more than two hours, lightheadedness when standing, heart rate above 100 beats per minute at rest, or blood pressure readings below 90/60 mmHg. These are the same warning signs the FDA prescribing information for sildenafil lists for drug-drug interactions with stronger vasodilators [1].

Lab Values Worth Tracking

If you receive IV glutathione regularly and take sildenafil, ask your provider to check a resting blood pressure at each infusion visit. No specific serum biomarker reliably predicts the interaction, but tracking blood pressure longitudinally gives early warning.

Drug Interactions to Prioritize Over Glutathione

The interactions that matter most with sildenafil are not supplement interactions. Strong CYP3A4 inhibitors like ritonavir can increase sildenafil AUC by 1,000%, requiring dose reduction to 25 mg no more than every 48 hours [1]. Nitrates remain absolutely contraindicated. Alpha-blockers require careful titration. Glutathione supplements rank well below all of these on the clinical priority list.

Specific Populations Who Should Exercise More Caution

Men With Cardiovascular Disease

The Princeton Consensus Panel (Third Princeton Consensus, 2012) stratified ED patients by cardiovascular risk for PDE5 inhibitor prescribing [9]. Men in the high-risk category (recent MI, unstable angina, refractory heart failure) are generally not candidates for sildenafil at all, regardless of what supplements they take. In intermediate-risk patients, any intervention affecting vascular tone, including IV glutathione, should be discussed with a cardiologist.

Patients Using Sildenafil for Pulmonary Arterial Hypertension

Revatio (sildenafil 20 mg three times daily) is prescribed for pulmonary arterial hypertension, a population that already has compromised hemodynamic reserve [1]. Adding glutathione infusions in this context should be done only under specialist supervision.

Individuals Taking Sildenafil Off-Label

Sildenafil is sometimes used off-label for altitude sickness, Raynaud phenomenon, and female sexual dysfunction. In these contexts, dosing strategies differ from the standard ED protocol, and the margin for additive vasodilation may be narrower.

What Clinicians Say About Supplement-PDE5 Inhibitor Combinations

The American Urological Association 2018 guideline on erectile dysfunction states: "Clinicians should inform patients about the increased risk of symptomatic hypotension when PDE5 inhibitors are co-administered with antihypertensive medications, alpha-blockers, or other vasodilatory agents." [7] This language deliberately covers the broader class of vasodilatory agents, not just pharmaceutical drugs. Glutathione's mild vasodilatory effect places it within that framework.

Dr. Arthur Burnett, a Johns Hopkins urologist and AUA guideline author, has noted in peer-reviewed commentary that patients rarely disclose supplement use to prescribers, a gap that creates underreported interaction signals across the PDE5 inhibitor class [10].

Summary of Interaction Classification

The combination of oral glutathione and sildenafil carries a low interaction rating by the mechanism-based criteria used in Natural Medicines Comprehensive Database. Injectable glutathione combined with sildenafil carries a moderate interaction rating based on additive vasodilation potential. Neither combination is listed as an absolute contraindication in any current FDA-approved prescribing document or major clinical guideline, but the pharmacodynamic rationale for caution, particularly with injectable forms, is sound.

A reasonable clinical rule: tell every prescriber you work with about every supplement you take, including glutathione. The two-hour oral separation window is a low-cost precaution. Anyone receiving IV glutathione on a regular schedule should bring their sildenafil prescription to the infusion clinic so the supervising clinician can document the combination.